human rab25 Search Results


92
OriGene full length human rab25 cdna
(A) Representative images of ECs expressing RFP-Rab10 WT and stained for Col IV (green). Green arrowheads indicate CIVCs only and yellow arrowheads indicate Rab10 puncta only. (B) Representative images of scramble, Rab10, <t>Rab25,</t> or LH3 siRNA-treated ECs and stained for Col IV (red), actin (green), and DNA (blue). Arrowheads denote extracellular Col IV secretion. (C) Graph of extracellular Col IV ratio of scramble, Rab10, Rab25, or LH3 siRNA-treated ECs cultured in SS media. (D) Representative images of fibrin-bead sprouts between indicated siRNA treatment groups. Sprouts were stained for actin (grey) to delineate sprout morphology. (E-G) Graphs of sprouting parameters for scramble, Rab10, Rab25, or LH3 siRNA-treated sprouts. (H) Representative images of ECs cultured in VEGF-containing or SS media and stained for Col IV (green), LH3 (red), and DNA (blue). Green arrowheads indicate CIVCs only and yellow arrowheads indicate co-localized puncta. (I) Graph of percent CIVC vesicles co-localized with LH3 in ECs cultured in VEGF-containing or SS media. (J) Representative images of scramble, Rab10, Rab25, or both Rab10/25 siRNA-treated ECs and stained for Col IV (green), LH3 (red), actin (grey), and DNA (blue). Yellow arrowheads indicate co-localized puncta only, green arrowheads indicate Col IV only puncta, and red arrowheads indicate LH3 puncta only. (K) Graph of percent CIVC vesicles co-localized with LH3 in scramble, Rab10, Rab25, or LH3 siRNA-treated conditions cultured in SS media or SS media with CLQ (10µM). (L) Representative images of ECs expressing RFP-Rab10 WT, CA, DN, stained for Col IV (green) and LH3 (blue). Yellow arrowheads indicate co-localized puncta only, green arrowheads indicate Col IV puncta, and red arrowheads indicate LH3 puncta. (M) Graph of percent CIVC vesicles co-localized with LH3 in ECs expressing RFP-Rab10 WT, CA or DN. (N) Graph of percent Rab10 puncta co-localized with Rab25 in either VEGF containing or SS media. (O) Graph of percent Rab10 puncta co-localized with Rab25 in ECs transfected with indicated constructs. (P) Representative images of WT or Rab10 +/- mice retinas harvested at P6. Retinas were stained for Col IV (red), LH3 (blue) and IB4 (green) to identify blood vessels. (Q) Graph of percent CIVCs containing LH3 in WT or Rab10 +/- P6 mouse retinas. (R) Schematic diagram showing how Rab10 and Rab25 function to coordinate delivery of LH3 to CIVCs for proper secretion of Col IV. Trans-Golgi network (TGN). For all experiments, data are represented as mean ± 95% confidence intervals. Black bars indicate comparison groups with indicated p-values. All p-values are from two-tailed Student’s t-test from at least three experiments. *p≤0.05; **p≤0.01; ***p≤0.001; ****p≤0.0001; ns, not significant.
Full Length Human Rab25 Cdna, supplied by OriGene, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/full length human rab25 cdna/product/OriGene
Average 92 stars, based on 1 article reviews
full length human rab25 cdna - by Bioz Stars, 2026-06
92/100 stars
  Buy from Supplier

93
Cusabio polyclonal anti rab25 antibody
Sequences of primers, miRNAs, and siRNAs used in this study.
Polyclonal Anti Rab25 Antibody, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/polyclonal anti rab25 antibody/product/Cusabio
Average 93 stars, based on 1 article reviews
polyclonal anti rab25 antibody - by Bioz Stars, 2026-06
93/100 stars
  Buy from Supplier

90
Abnova anti-human rab25
Sequences of primers, miRNAs, and siRNAs used in this study.
Anti Human Rab25, supplied by Abnova, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-human rab25/product/Abnova
Average 90 stars, based on 1 article reviews
anti-human rab25 - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

N/A
qSTAR qPCR primer pairs against Homo sapiens gene RAB25
  Buy from Supplier

N/A
Rabbit anti-Human RAB25 Polyclonal Antibody
  Buy from Supplier

N/A
RAB25 Human 4 unique 29mer shRNA constructs in retroviral untagged vector
  Buy from Supplier

N/A
Human RAB25 Protein Lysate 20ug from Innovative Research is provided as a Lyophilized powder. This is a Recombinant Protein Lysate produced in HEK293T cells. This protein lysate can be reconsituted using SDS Sample Buffer. Once
  Buy from Supplier

N/A
Using a secreted and robust Gaussia Luciferase (GLuc) as the reporter, GeneCopoeia GLuc-ON™ promoter clones are designed for promoter analysis by detecting the real-time activities of about 39,500 human, 28,700 mouse and 17,500 rat promoters
  Buy from Supplier

N/A
Full length Clone DNA of Human RAB25 member RAS oncogene family with C terminal GFPSpark tag
  Buy from Supplier

N/A
RAB25 CRISPRa kit CRISPR gene activation of human RAB25 member RAS oncogene family
  Buy from Supplier

N/A
The Recombinant Human Rab25 Protein has been validated for the following applications Western Blot ELISA Protein Array Immunoaffinity Purification
  Buy from Supplier

Image Search Results


(A) Representative images of ECs expressing RFP-Rab10 WT and stained for Col IV (green). Green arrowheads indicate CIVCs only and yellow arrowheads indicate Rab10 puncta only. (B) Representative images of scramble, Rab10, Rab25, or LH3 siRNA-treated ECs and stained for Col IV (red), actin (green), and DNA (blue). Arrowheads denote extracellular Col IV secretion. (C) Graph of extracellular Col IV ratio of scramble, Rab10, Rab25, or LH3 siRNA-treated ECs cultured in SS media. (D) Representative images of fibrin-bead sprouts between indicated siRNA treatment groups. Sprouts were stained for actin (grey) to delineate sprout morphology. (E-G) Graphs of sprouting parameters for scramble, Rab10, Rab25, or LH3 siRNA-treated sprouts. (H) Representative images of ECs cultured in VEGF-containing or SS media and stained for Col IV (green), LH3 (red), and DNA (blue). Green arrowheads indicate CIVCs only and yellow arrowheads indicate co-localized puncta. (I) Graph of percent CIVC vesicles co-localized with LH3 in ECs cultured in VEGF-containing or SS media. (J) Representative images of scramble, Rab10, Rab25, or both Rab10/25 siRNA-treated ECs and stained for Col IV (green), LH3 (red), actin (grey), and DNA (blue). Yellow arrowheads indicate co-localized puncta only, green arrowheads indicate Col IV only puncta, and red arrowheads indicate LH3 puncta only. (K) Graph of percent CIVC vesicles co-localized with LH3 in scramble, Rab10, Rab25, or LH3 siRNA-treated conditions cultured in SS media or SS media with CLQ (10µM). (L) Representative images of ECs expressing RFP-Rab10 WT, CA, DN, stained for Col IV (green) and LH3 (blue). Yellow arrowheads indicate co-localized puncta only, green arrowheads indicate Col IV puncta, and red arrowheads indicate LH3 puncta. (M) Graph of percent CIVC vesicles co-localized with LH3 in ECs expressing RFP-Rab10 WT, CA or DN. (N) Graph of percent Rab10 puncta co-localized with Rab25 in either VEGF containing or SS media. (O) Graph of percent Rab10 puncta co-localized with Rab25 in ECs transfected with indicated constructs. (P) Representative images of WT or Rab10 +/- mice retinas harvested at P6. Retinas were stained for Col IV (red), LH3 (blue) and IB4 (green) to identify blood vessels. (Q) Graph of percent CIVCs containing LH3 in WT or Rab10 +/- P6 mouse retinas. (R) Schematic diagram showing how Rab10 and Rab25 function to coordinate delivery of LH3 to CIVCs for proper secretion of Col IV. Trans-Golgi network (TGN). For all experiments, data are represented as mean ± 95% confidence intervals. Black bars indicate comparison groups with indicated p-values. All p-values are from two-tailed Student’s t-test from at least three experiments. *p≤0.05; **p≤0.01; ***p≤0.001; ****p≤0.0001; ns, not significant.

Journal: bioRxiv

Article Title: Notch Regulates Vascular Collagen IV Basement Membrane Through Modulation of Lysyl Hydroxylase 3 Trafficking

doi: 10.1101/2020.06.22.165431

Figure Lengend Snippet: (A) Representative images of ECs expressing RFP-Rab10 WT and stained for Col IV (green). Green arrowheads indicate CIVCs only and yellow arrowheads indicate Rab10 puncta only. (B) Representative images of scramble, Rab10, Rab25, or LH3 siRNA-treated ECs and stained for Col IV (red), actin (green), and DNA (blue). Arrowheads denote extracellular Col IV secretion. (C) Graph of extracellular Col IV ratio of scramble, Rab10, Rab25, or LH3 siRNA-treated ECs cultured in SS media. (D) Representative images of fibrin-bead sprouts between indicated siRNA treatment groups. Sprouts were stained for actin (grey) to delineate sprout morphology. (E-G) Graphs of sprouting parameters for scramble, Rab10, Rab25, or LH3 siRNA-treated sprouts. (H) Representative images of ECs cultured in VEGF-containing or SS media and stained for Col IV (green), LH3 (red), and DNA (blue). Green arrowheads indicate CIVCs only and yellow arrowheads indicate co-localized puncta. (I) Graph of percent CIVC vesicles co-localized with LH3 in ECs cultured in VEGF-containing or SS media. (J) Representative images of scramble, Rab10, Rab25, or both Rab10/25 siRNA-treated ECs and stained for Col IV (green), LH3 (red), actin (grey), and DNA (blue). Yellow arrowheads indicate co-localized puncta only, green arrowheads indicate Col IV only puncta, and red arrowheads indicate LH3 puncta only. (K) Graph of percent CIVC vesicles co-localized with LH3 in scramble, Rab10, Rab25, or LH3 siRNA-treated conditions cultured in SS media or SS media with CLQ (10µM). (L) Representative images of ECs expressing RFP-Rab10 WT, CA, DN, stained for Col IV (green) and LH3 (blue). Yellow arrowheads indicate co-localized puncta only, green arrowheads indicate Col IV puncta, and red arrowheads indicate LH3 puncta. (M) Graph of percent CIVC vesicles co-localized with LH3 in ECs expressing RFP-Rab10 WT, CA or DN. (N) Graph of percent Rab10 puncta co-localized with Rab25 in either VEGF containing or SS media. (O) Graph of percent Rab10 puncta co-localized with Rab25 in ECs transfected with indicated constructs. (P) Representative images of WT or Rab10 +/- mice retinas harvested at P6. Retinas were stained for Col IV (red), LH3 (blue) and IB4 (green) to identify blood vessels. (Q) Graph of percent CIVCs containing LH3 in WT or Rab10 +/- P6 mouse retinas. (R) Schematic diagram showing how Rab10 and Rab25 function to coordinate delivery of LH3 to CIVCs for proper secretion of Col IV. Trans-Golgi network (TGN). For all experiments, data are represented as mean ± 95% confidence intervals. Black bars indicate comparison groups with indicated p-values. All p-values are from two-tailed Student’s t-test from at least three experiments. *p≤0.05; **p≤0.01; ***p≤0.001; ****p≤0.0001; ns, not significant.

Article Snippet: Full-length human Rab25 cDNA was purchased from Origene (RC203413, ORIgene) and cloned into pME-MCS as described supplementary table 1.

Techniques: Expressing, Staining, Cell Culture, Transfection, Construct, Two Tailed Test

(A) Representative images of ECs co-expressing RFP-Rab10 WT and BFP-Rab25 WT in VEGF containing either VEGF-containing or SS media Yellow arrowheads denote co-localized Rab10 and Rab25 puncta, red arrowheads denote Rab10 puncta only, and green arrowheads denote Rab25 puncta only. (B) Representative images of ECs transfected to co-expression RFP-Rab10 WT, CA or DN and BFP-Rab25 WT, CA or DN cultured in SS media. Yellow arrowheads denote co-localized Rab10 and Rab25 puncta, red arrowheads denote Rab10 puncta only, and green arrowheads denote Rab25 puncta only. (C) Representative images of scramble and Rab25 siRNA-treated ECs cultured in SS media and stained for Col IV (grey). Dotted red and green lines indicates CIVC vesicle positive or negative ECs, respectively. Arrowheads denote CIVC vesicles. (D) Graph of number of ECs containing CIVC vesicles in scramble, Rab10, Rab25, and LH3 siRNA-treated ECs cultured in SS media. (E) Representative images of ECs transfected with either scramble or Vps33b siRNA and stained for Col IV (red), actin (green), and DNA (blue). Dotted green line indicates cell outline. Arrowheads denote extracellular Col IV secretion. (F) Graph of extracellular Col IV ratio of indicated siRNA treated ECs. n, number of measurements. (G) Representative images of ECs transfected with either scramble or Vps33b siRNA and stained for Col IV (red), LH3 (green), actin (light blue), and DNA (blue). Yellow arrowheads indicate co-localized puncta only, green arrowheads indicate Col IV only puncta, and red arrowheads indicate LH3 puncta only. (H) Graph of percent CIVCs containing LH3 in scramble or Vps33b-siRNA treated ECs. For all experiments, data are represented as mean ± 95% confidence intervals. Black bars indicate comparison groups with indicated p-values. All p-values are from two-tailed Student’s t-test from at least three experiments. *p≤0.05; **p≤0.01; ***p≤0.001; ****p≤0.0001; ns, not significant.

Journal: bioRxiv

Article Title: Notch Regulates Vascular Collagen IV Basement Membrane Through Modulation of Lysyl Hydroxylase 3 Trafficking

doi: 10.1101/2020.06.22.165431

Figure Lengend Snippet: (A) Representative images of ECs co-expressing RFP-Rab10 WT and BFP-Rab25 WT in VEGF containing either VEGF-containing or SS media Yellow arrowheads denote co-localized Rab10 and Rab25 puncta, red arrowheads denote Rab10 puncta only, and green arrowheads denote Rab25 puncta only. (B) Representative images of ECs transfected to co-expression RFP-Rab10 WT, CA or DN and BFP-Rab25 WT, CA or DN cultured in SS media. Yellow arrowheads denote co-localized Rab10 and Rab25 puncta, red arrowheads denote Rab10 puncta only, and green arrowheads denote Rab25 puncta only. (C) Representative images of scramble and Rab25 siRNA-treated ECs cultured in SS media and stained for Col IV (grey). Dotted red and green lines indicates CIVC vesicle positive or negative ECs, respectively. Arrowheads denote CIVC vesicles. (D) Graph of number of ECs containing CIVC vesicles in scramble, Rab10, Rab25, and LH3 siRNA-treated ECs cultured in SS media. (E) Representative images of ECs transfected with either scramble or Vps33b siRNA and stained for Col IV (red), actin (green), and DNA (blue). Dotted green line indicates cell outline. Arrowheads denote extracellular Col IV secretion. (F) Graph of extracellular Col IV ratio of indicated siRNA treated ECs. n, number of measurements. (G) Representative images of ECs transfected with either scramble or Vps33b siRNA and stained for Col IV (red), LH3 (green), actin (light blue), and DNA (blue). Yellow arrowheads indicate co-localized puncta only, green arrowheads indicate Col IV only puncta, and red arrowheads indicate LH3 puncta only. (H) Graph of percent CIVCs containing LH3 in scramble or Vps33b-siRNA treated ECs. For all experiments, data are represented as mean ± 95% confidence intervals. Black bars indicate comparison groups with indicated p-values. All p-values are from two-tailed Student’s t-test from at least three experiments. *p≤0.05; **p≤0.01; ***p≤0.001; ****p≤0.0001; ns, not significant.

Article Snippet: Full-length human Rab25 cDNA was purchased from Origene (RC203413, ORIgene) and cloned into pME-MCS as described supplementary table 1.

Techniques: Expressing, Transfection, Cell Culture, Staining, Two Tailed Test

Sequences of primers, miRNAs, and siRNAs used in this study.

Journal: Virulence

Article Title: MiR-140 inhibits classical swine fever virus replication by targeting Rab25 in swine umbilical vein endothelial cells

doi: 10.1080/21505594.2020.1735051

Figure Lengend Snippet: Sequences of primers, miRNAs, and siRNAs used in this study.

Article Snippet: The membrane was blocked with the polyclonal anti-Rab25 antibody (CSB-PA019175LA01HU, cusabio), and monoclonal anti-β-actin antibody (AB0035, Abways).

Techniques: Sequencing, Over Expression, Knockdown